Literature DB >> 15279314

Psychometric properties of the Norwegian version of the Dysfunctional Attitude Scale (Form A).

Andrea P Chioqueta1, Tore C Stiles.   

Abstract

The present study reports the reliability and validity of the Norwegian version of the Dysfunctional Attitude Scale in non-clinical and clinical populations. The participants were 344 young male military recruits, 41 healthy controls and 142 psychiatric outpatients. All the participants completed the Dysfunctional Attitude Scale, the Beck Depression Inventory and the Automatic Thoughts Questionnaire. The analysis of the Dysfunctional Attitude Scale revealed a Cronbach's alpha of 0.85, indicating satisfactory reliability. Evidence for the construct validity was obtained by the correlation between the Dysfunctional Attitude Scale and the Beck Depression Inventory (r = 0.47) and the Dysfunctional Attitude Scale and the Automatic Thoughts Questionnaire (r = 0.47). Finally, the Dysfunctional Attitude Scale significantly discriminated between clinically depressed, non-depressed psychiatric patients and healthy controls. The results showed that the Norwegian version of the Dysfunctional Attitude Scale possess satisfactory psychometric properties suggesting that this instrument is appropriate for use as a cognitive measure in a Norwegian cultural context.

Entities:  

Mesh:

Year:  2004        PMID: 15279314     DOI: 10.1080/16506070410023951

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  2 in total

1.  Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.

Authors:  Robin B Jarrett; Michael E Thase
Journal:  Contemp Clin Trials       Date:  2010-05-06       Impact factor: 2.226

2.  Measuring cognitive errors using the Cognitive Distortions Scale (CDS): psychometric properties in clinical and non-clinical samples.

Authors:  Kadir Özdel; Ibrahim Taymur; Seher Olga Guriz; Riza Gökcer Tulaci; Erkan Kuru; Mehmet Hakan Turkcapar
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.